Notre actualité
Since the beginning of this year we have created four webinars to present our BIOMIMESYS® technology and practical uses. We have chosen to focus on the scientific side of our innovation by presenting results in drug discovery or dermocosmetology domains. Theses four webinars are available on our support page (with many Read more…
Maybe you are looking for a solution for your 3D cell culture and, after a Google or a Pubmed search, you find us and the BIOMIMESYS® technology. Or, you saw a publication or a poster about our research and you came here to better know what we do. Whatever your Read more…
Please feel free to follow us in these conferences: on Thursday 27th, we will attend the virtual Joint Meeting of the French and German Societies for Matrix Biology. Let’s talk about BIOMIMESYS technology (poster n°105, poster session 2) and BIOMIMESYS Adipose Tissue in particular (poster n°97, poster session 1)! You Read more…
The annual congress of the SCMC (Societé Cerveau et Maldies Cérébraux Vasculaires – Brain and cerebrovascular diseases Society) will take place this Friday, may 28 2021 (virtual congress). On this occasion, our PhD student Véronique De Conto will present her PhD works, which concern the development of new cerebral in Read more…
We have a new arrival in our laboratory! As part of her diploma “DUT Génie Biologique”, specialized in biological and biochemistry analysis, Laura has joined us for a four months’ internship in dermocosmetology, in order to develop in vitro antipollution test. Already graduated of bachelor’s degrees in biology, she currently Read more…
Raising funds in Europe when we carry a disruptive technology such as BIOMIMESYS technology which requires substantial financial investment for R&D is not so easy. Fortunately, Europe has understood this well and is helping entrepreneurs in this laborious task. In 2020, we entered the Invest Horizon coaching program. We were Read more…
We are very please to welcome two new members in our scientific advisory board. Dr Vincent Senez from the Institute of Cancer Research of Lille (IRCL) is specialized in microfluidics and lab-on-a-chip technologies. We work together on several projects to implement a specific version of our BIOMIMESYS® hydroscaffold to create Read more…
If you want to better known what we are doing now in HCS Pharma and if your native language is korean, you can discover it with this article : HCS Pharma, 생리학적으로 중요한 3d Cell Model의 Phenotypic Screening에 ImageXpress Micro Confocal 시스템 사용 We explain in the text how we Read more…
When Tuesday, June 1, 2021 – 1PM (CET) / 8PM (CST) / 9PM (JST) / 7AM (EST) Thursday, June 3, 2021 – 9AM (CET) / 4PM (CST) / 5PM (JST) / 3AM (EST) Where Online, using zoom.us and live on Youtube What Pharmaceutical industry is facing a very high failure rate in Read more…
Our entire product range BIOMIMESYS® is now available in the new catalogue 2021 of Dominique Dutscher company. You can find it in the paper one but also in the “cell culture” e-catalogue on page 7 (available below in french). You can also find our products on the DUTSCHER’s website. Thanks Read more…
When Tuesday, April 20, 2021 – 1PM (CET) / 8PM (CST) / 9PM (JST) / 7AM (EST) Thursday, April 22, 2021 – 9AM (CET) / 4PM (CST) / 5PM (JST) / 3AM (EST) Where Online, using zoom.us and live on Youtube What 3D cell culture systems have recently emerged as promising tools Read more…
We are very happy to welcome Lucille in our laboratory. Lucille is currently finishing a master degree in Biotechnologies at AgroParisTech, a French engineering school. During her studies, she had the opportunity to work with 3D vascularised cellular models in the Herland Lab of KTH, Royal Institute of Technology, in Read more…
We are very happy to invite you to our next webinar about 3D cellular cancer models and our BIOMIMESYS® Oncology matrix which allows cancer cells to be cultured in a tumor-like environment, with the possibility to tune the composition and stiffness of the matrix. We will also share our best Read more…
It was a great pleasure to present our technology BIOMIMESYS for relevant 3D cell cultures, and its applications in oncology field in the frame of ONCOLille seminars. All the questions and discussions at the end of our presentation convinced us that BIOMIMESYS is of great interest to oncology researchers, in Read more…
During the next Molecular Devices online event called “From organoids to cell painting: Investigate 3D and complex biology using advanced methods in high-content cellular imaging and analysis” we will present how to generate functional human liver organoids derived from hiPSC in BIOMIMESYS® hydroscaffold. This virtual user meeting and workshop is Read more…
When Tuesday, March 23, 2021 – 1PM (CET) / 8PM (CST) / 9PM (JST) / 7AM (EST) Thursday, March 25, 2021 – 9AM (CET) / 4PM (CST) / 5PM (JST) / 3AM (EST) Where Online, using zoom.us and live on Youtube What 3D cell culture systems have recently emerged as promising tools Read more…
Nous sommes heureux de vous annoncer que le Ministère de l’Enseignement Supérieur et de la Recherche a accordé à HCS Pharma l’agrément au Crédit d’Impôt Recherche (CIR) jusqu’en 2023, en regard de nos activités de R&D. For non-french readers, the CIR (Research Tax Credit) concept is explain here. Our customers can Read more…
We are pleased and proud to welcome Dr Philippe Manivet and Dr Anthony Trezeibre in our Scientific Advisory Board. We are developing new innovative projects with them around our BIOMIMESYS technology. Because our BIOMIMESYS technology is requested in different fields and we want to stay at the forefront of innovation, Read more…
When Tuesday, February 23, 2021 – 1PM (CET) / 8PM (CST) / 9PM (JST) / 7AM (EST) Thursday, February 25, 2021 – 9AM (CET) / 4PM (CST) / 5PM (JST) / 3AM (EST) Where Online, using zoom.us and live on Youtube What 3D cell culture systems have recently as promising Read more…
We wish you a great year 2021, with great success in your all your projects. Here at HCS Pharma, we strongly believed that 3D cell culture in adequat medium is a key factor for successful drug discovery projects. To help you as efficiently as possible we have modified this website. Read more…
Step by step we are getting closer to 2021, after a very particular and, for some of us, very difficult 2020 year. 2021 will be THE year of 3D cell culture in many research applications such as drug discovery for complex diseases or cancers. We will be happy to facilitate Read more…
We are very pleased to announce that Meryl, our first CIFRE PhD student, defended his doctoral thesis last week! His PhD work was dealing with the use of pluripotent stem cells to study liver diseases. He has also developed an innovative model to obtain liver organoïds in our BIOMIMESYS® product. Read more…
HCS Pharma is pleased to present the whole range of BIOMIMESYS® Products. All our scientific team is ready to support you in using our 3D organ/tissue-specific cell-culture technology. Rediscover your cells in real in vitro 3D-culture conditions with our special evaluation plate format . You can find our presentation in Read more…